CLINICAL_TRIALS
trial_result
· 2012-09-20
Clinical Trial Update: Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study [Phase 4]
Summary
A Phase 4 pilot trial evaluates how timing affects the efficacy of Zegerid 40 mg in healing erosive esophagitis, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yvonne Romero | Conditions: Erosive Esophagitis | Phase 4 | Status: COMPLETED | Results posted: 2012-09-20